AP NEWS

Pharmacy Times Continuing Education™ Presents a Live Broadcast on Chronic Lymphocytic Leukemia

August 22, 2018

CRANBURY, N.J.--(BUSINESS WIRE)--Aug 22, 2018--Pharmacy Times Continuing Education™ ( PT CE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will host the live video broadcast “Novel Immunotherapy Options for the Long-term Care of Patients with Chronic Lymphocytic Leukemia (CLL): The Role of Clinical and Specialty Pharmacists.” The webinar will take place Tuesday, September 18, at 7 p.m. ET.

“Clinical advances in CLL have improved patient outcomes, but often involve complex treatment strategies that require collaboration between clinical and specialty pharmacists,” said Jim Palatine, RPh, MBA, president of PT CE . “We are thrilled to have the resources to present this interactive, discussion-based broadcast on the importance of integrating new and emerging CLL agents into the current treatment paradigm to enhance patient care live to our participants. Clinical and specialty pharmacists need to stay up-to-date on the ever-changing landscape of CLL management, and this live broadcast will offer them a great opportunity to interact with experts on a topic of critical importance.”

Faculty presenters for the webinar include:

Christopher A. Fausel, PharmD, MHA, BCOP, clinical manager, oncology pharmacy, Indiana University Health; chairman of the board, Hoosier Cancer Research Network Julianne Orr, PharmD, BCOP, outpatient oncology clinical pharmacist, department of pharmacy, Indiana University Health Simon Cancer Center

With the expertise of faculty, this webinar will illustrate current and novel treatments for CLL and highlight the importance of integrating these agents into treatment paradigms. The presenters will also discuss the role of BCR-associated kinases, such as Bruton tyrosine kinase and phosphoinositide 3-kinase, and other inhibitors of BCR signaling in CLL treatment. Additionally, participants will learn strategies to manage and counsel patients with CLL.

This activity is supported by educational grants from Pharmacyclics LLC. An AbbVie company; Janssen Biotech, Inc.; and CURE Media Group.

PT CE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Attendees are eligible to earn 1.5 contact hours (0.15 CEU). For registration and more information, visit https://www.pharmacytimes.org/live/immunotherapy-options-longterm-care-cll.

About  Pharmacy Times  Continuing Education™

Pharmacy Times  Continuing Education™ ( PT CE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists.  PT CE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PT CE’s print, online and live CPE activities are designed to help improve the knowledge, competence and skills of pharmacists so that they are better prepared to provide the highest quality of pharmacy care to the patients they serve and to the physicians they assist as part of a multidisciplinary treatment/management team. To learn more about the educational activities sponsored by  PT CE, visit https://www.pharmacytimes.org/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180822005564/en/

CONTACT: PTCE Media

Theresa Burek, 609-325-4811

tburek@mjhassoc.com

and

Alexandra Ventura, 609-716-7777, ext. 121

aventura@mjhassoc.com

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL RESEARCH OTHER SCIENCE SCIENCE MANAGED CARE

SOURCE: Pharmacy Times Continuing Education

Copyright Business Wire 2018.

PUB: 08/22/2018 01:29 PM/DISC: 08/22/2018 01:29 PM

http://www.businesswire.com/news/home/20180822005564/en

AP RADIO
Update hourly